Page 6642: in the first paragraph under “First-line setting: patterns of care and TTNT,” in the sentence that begins “In the first-line setting, there were 27 different therapeutic regimens prescribed,” the parenthetical citation should read “Table 2 and supplemental Table 1,” not “supplemental Tables 1 and 2.”
In the next paragraph, in the sentence that begins “For the 2 most commonly prescribed first-line therapies,” the parenthetical citation should read “Table 2,” not “Table 3.”
In Table 2, in the column “N = 178 first-line treatments (%),” in the row “Histone deacetylase (HDAC) inhibitor monotherapy,” “4 (2.3)” should read “4 (2.2)”; in the row “Monoclonal antibody–based monotherapy∗,” “4 (2.3)” should read “4 (2.2)”; in the row “Interferon–based combination therapy,” “4 (2.3)” should read “4 (2.2)”; in the row “Skin–directed monotherapy only,” “4 (2.3)” should read “4 (2.2).” In the column “% free from next line of treatment at 2 years (95%CI),” in the row “ECP–based combination therapy,” “14.9 (40.9-30.0)” should read “14.9 (4.9-30.0).”
Page 6643: under “Across all lines of therapy: patterns of care and TTNT,” the sentence “The median TTNT for all lines (n = 99) was 8.7 (95% CI, 6.2-11.6) months with 20.4% (95% CI, 11.5-31.2) free from next line of therapy at 2 years (Table 3)” should read “The median TTNT for all lines of monoclonal antibody-based therapies (n = 99) was 8.7 (95% CI, 6.2-11.9) months with 20.4% (95% CI, 11.5-31.2) free from next line of therapy at 2 years (Table 3).”
In Table 3, in the column “Median TTNT (months) (95% CI),” in the row “Histone deacetylase (HDAC) inhibitor monotherapy,” “60 (3.3-7.9)” should read “6.0 (3.3-7.9)”; in the row “Monoclonal antibody–based monotherapy,” “8.7 (6.2-11.6)” should read “8.7 (6.2-11.9).” In the column “% free from next line of treatment at 1 year (95% CI),” in the row “Other combinations of systemic therapies,” “9.5% (0.8-32.2)” should read “9.5 (0.8-32.2).”
In Supplementary Table S2, in the column “N=178 patients∗,” in the row “Systemic chemotherapy, single agent monotherapy∗∗,” “76 (43.3%)” should read “76 (42.7%)”; in the row “Other combinations of systemic therapies,” “14 (7.8%)” should read “14 (7.9%).”
The corrected supplemental file is available in the HTML version of this erratum.